We are live on
!
Find out more
Immunic
IMUX
IMUX
43 hedge funds and large institutions have $1.16M invested in Immunic in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0.04% → 0.03% (-0%)
4% less capital invested
Capital invested by funds: $1.22M → $1.16M (-$53.6K)
9% less funds holding
Funds holding: 47 → 43 (-4)
31% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 16
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
43
Holders Change
-4
Holders Change %
-8.51%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
16
Closed
8
Calls
$49K
Puts
–
Net Calls
+$49K
Net Calls Change
+$5K
Top Buyers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$77K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$17.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.1K |
| 4 |
SG Americas Securities
New York
|
+$13.4K |
| 5 |
Goldman Sachs
New York
|
+$8.7K |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$117K |
| 2 |
VF
Virtu Financial
New York
|
-$58K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.4K |
| 4 |
Two Sigma Investments
New York
|
-$25.6K |
| 5 |
BlackRock
New York
|
-$16.6K |
